Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome

Sharon I. King, Colin A. Purdie, Susan E. Bray, Philip R. Quinlan, Lee B. Jordan, Alastair M. Thompson, David W. Meek (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    72 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome'. Together they form a unique fingerprint.

    Medicine & Life Sciences